Intraperitoneal hyaluronan administration in conscious rats: Absorption, metabolism, and effects on peritoneal fluid dynamics

Peritoneal Dialysis International

Volumn 21, Issue 2, 2001, Pages 130-135

  Breborowicz, Andrzej ^a   Polubinska, Alicja ^a   Pawlaczyk, Krzysztof ^a   Kuzlan Pawlaczyk, Malgorzata ^a   Moberly, James ^b   Martis, Leo ^b   Oreopoulos, Dimitrios ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hyaluronan; Metabolism; Peritoneal absorption; Uremia

Indexed keywords

CREATININE; DIANEAL; GLUCOSE; HYALURONIC ACID; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG TISSUE LEVEL; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PERITONEAL CAVITY; PERITONEAL FLUID; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; ULTRAFILTRATION; UREMIA;

EID: 0035004023     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102100204     Document Type: Article

References (25)

1. Yung S, Coles GA, Davies M. IL-1β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50:1337-43.
2. Breborowicz A, Wisniewska J, Polubinska A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis. Perit Dial Int 1998; 18:382-6.
3. Yamagata K, Tomida C, Nishiki K, Kobayashi M, Koyama A. Longitudinal follow-up of hyaluronan in peritoneal effluent (Abstract). Perit Dial Int 1998; 18(Suppl 1):S9.
4. Wieczorowska K, Breborowicz A, Martis L, Oreopoulos DG. Protective effect of hyaluronic acid against peritoneal injury. Perit Dial Int 1995; 15:81-3.
5. Wang T, Chen C, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis. J Am Soc Nephrol 1998; 8:1915-20.
6. Wang T, Cheng HH, Heimbürger O, Chen C, Waniewski J, Bergström J, et al. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan. Kidney Int 1999; 55:667-73.
7. Breborowicz A, Radkowski M, Knapowski J, Oreopoulos DG. Effects of chondroitin sulphate on fluid and solute transport during peritoneal dialysis. Perit Dial Int 1991; 11:351-4.
8. Flessner MF, Parker RJ, Sieber SM. Peritoneal lymphatic uptake of fibrinogen and erythrocytes in the rat. Am J Physiol 1983; 244:H89-96.
9. 14C)SPH in rat after intravenous, subcutaneous and intramuscular administration. Ohyoh Butsuri 1987; 33:849-57.
10. Laurent UBG, Reed RK. Turnover of hyaluronan in the tissues. Adv Drug Deliv Rev 1991; 7:237-56.
11. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
12. Kuzlan M, Pawlaczyk K, Wieczorowska-Tobis K, Korybalska K, Breborowicz A, Oreopoulos DG. Peritoneal surface area and its permeability in rats. Perit Dial Int 1997; 17:295-300.
13. Lam LS, Bert JL. Hydraulic conductivity of hyaluronic acid solutions: effects of concentration and molecular weight. Biorheology 1990; 27:789-95.
14. Ogston AG, Sherman TF. Effects of hyaluronic acid upon diffusion of solutes and flow of solvent. J Physiol 1961; 156:67-74.
15. Honkanen RA, McBath H, Kushmerick C, Callender GE, Scarlata SF, Fenstermacher JD, et al. Barbiturates inhibit hexose transport in cultured mammalian cells and human erythrocytes and interact directly with purified GLUT-1. Biochemistry 1995; 17:535-44.
16. Yuasa H, Matsuda K, Watanabe J. Influence of anesthetic regimens on the intestinal absorption of 5-fluorouracil in rats. Biol Pharm Bull 1995; 18:747-52.
17. Tran LP, Rodela H, Abernethy NJ, Yuan ZY, Hay JB, Oreopoulos D, et al. Lymphatic drainage of hypertonic solution from the peritoneal cavity of anesthetized and conscious sheep. Am J Physiol 1993; 74:859-67.
18. Wang T, Cheng HH, Guo QY, Lindholm B. Intraperitoneal use of pentobarbital changes peritoneal transport and peritoneal surface layer (Abstract). Peru Dial Int 2000; 20(Suppl 1):S17.
19. Edelstam GAB, Laurent UBG, Lundkvist OE, Fraser RE, Laurent TC. Concentration and turnover of intraperitoneal hyaluronan during inflammation. Inflammation 1992; 16:459-69.
20. Pawlaczyk K. Experimental rat model to study kinetics of peritoneal transport (Thesis). Poznañ, Poland: Poznan Medical School, 1999.
21. Smedsrod B, Pertoft H, Frikisson S, Fraser R, Laurent TC. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984; 223:617-26.
22. Fraser JR, Laurent TC, Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 1981; 200:415-24.
23. Lebel L, Fraser JRE, Kimpton WS, Gabrielsson J, Gerdin B, Laurent TC. A pharmacokinetic model of intravenously administered hyaluronan in sheep. Pharm Res 1989; 6:677-82.
24. Fraser JRE, Laurent TC, Engstrom-Laurent A, Laurent UGB. Elimination of hyaluronic acid from the blood stream in humans. Clin Exp Pharmacol Physiol 1984; 11:17-25.
25. Ostgaard G, Reed RK. Intravenous saline infusion in rat increases hyaluronan efflux in intestinal lymph by increasing lymph flow. Acta Physiol Scand 1993; 147:329-35.